Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Natural Course and Prognosis of Hospitalized Patients With Cirrhosis: a Prospective, Multicenter, and Observational Study

NCT05185154 is registered in ClinicalTrials.gov with Kangbuk Samsung Hospital as lead sponsor.

NCT NCT05185154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05185154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Natural Course and Prognosis of Hospitalized Patients With Cirrhosis: a Prospective, Multicenter, and Observational Study
Lead sponsor
Kangbuk Samsung Hospital
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2021
Completion date
October 31, 2025
Enrollment
336 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis